Evidence for AMPK-dependent regulation of exocytosis of lipoproteins in a model liver cell line

Experimental Cell Research

Volumn 314, Issue 10, 2008, Pages 2100-2109

  Puljak, Livia ^a   Parameswara, Vinay ^a   Dolovcak, Svjetlana ^a   Waldrop, Shar L ^a   Emmett, Daniel ^a   Esser, Victoria ^a   Fitz, J Gregory ^a   Kilic, Gordan ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

AMPK; Constitutive exocytosis; FM1 43; Intracellular lipids; Nile red

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; APOLIPOPROTEIN B; ETOMOXIR; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPID; LIPOPROTEIN; METFORMIN; TRIACYLGLYCEROL;

ANIMAL CELL; ARTICLE; CELL STIMULATION; ENZYME ACTIVATION; EXOCYTOSIS; FATTY ACID OXIDATION; LIPOPROTEIN SECRETION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

EID: 44749094644     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.03.002     Document Type: Article

References (38)

1. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., and Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest 108 (2001) 1167-1174
2. Zang M., Zuccollo A., Hou X., Nagata D., Walsh K., Herscovitz H., Brecher P., Ruderman N.B., and Cohen R.A. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J. Biol. Chem. 279 (2004) 47898-47905
3. Kahn B.B., Alquier T., Carling D., and Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1 (2005) 15-25
4. Minokoshi Y., Kim Y.B., Peroni O.D., Fryer L.G., Muller C., Carling D., and Kahn B.B. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415 (2002) 339-343
5. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., and Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8 (2002) 1288-1295
6. Lee Y., Wang M.Y., Kakuma T., Wang Z.W., Babcock E., McCorkle K., Higa M., Zhou Y.T., and Unger R.H. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J. Biol. Chem. 276 (2001) 5629-5635
7. Lin H.Z., Yang S.Q., Chuckaree C., Kuhajda F., Ronnet G., and Diehl A.M. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat. Med. 6 (2000) 998-1003
8. Bugianesi E., Gentilcore E., Manini R., Natale S., Vanni E., Villanova N., David E., Rizzetto M., and Marchesini G. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am. J. Gastroenterol. 100 (2005) 1082-1090
9. Vance J.E., and Vance D.E. Lipoprotein assembly and secretion by hepatocytes. Annu. Rev. Nutr. 10 (1990) 337-356
10. Kilic G., Angleson J.K., Cochilla A.J., Nussinovitch I., and Betz W.J. Sustained stimulation of exocytosis triggers continuous membrane retrieval in rat pituitary somatotrophs. J. Physiol. 532 (2001) 771-783
11. Puljak L., Pagliassotti M.J., Wei Y., Qadri I., Parameswara V., Esser V., Fitz J.G., and Kilic G. Inhibition of cellular responses to insulin in a rat liver cell line. A role for PKC in insulin resistance. J. Physiol. 563 (2005) 471-482
12. Kilic G., Doctor R.B., and Fitz J.G. Insulin stimulates membrane conductance in a liver cell line: evidence for insertion of ion channels through a phosphoinositide 3-kinase-dependent mechanism. J. Biol. Chem. 276 (2001) 26762-26768
13. Cochilla A.J., Angleson J.K., and Betz W.J. Monitoring secretory membrane with FM1-43 fluorescence. Annu. Rev. Neurosci. 22 (1999) 1-10
14. Smith C.B., and Betz W.J. Simultaneous independent measurement of endocytosis and exocytosis. Nature 380 (1996) 531-534
15. Kilic G. Exocytosis in bovine chromaffin cells: studies with patch-clamp capacitance and FM1-43 fluorescence. Biophys. J. 83 (2002) 849-857
16. Lindau M., and Neher E. Patch-clamp techniques for time-resolved capacitance measurements in single cells. Pflugers Arch. 411 (1988) 137-146
17. Letteron P., Sutton A., Mansouri A., Fromenty B., and Pessayre D. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology 38 (2003) 133-140
18. Gilham D., Ho S., Rasouli M., Martres P., Vance D.E., and Lehner R. Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion. FASEB J. 17 (2003) 1685-1687
19. Taghibiglou C., Carpentier A., Van Iderstine S.C., Chen B., Rudy D., Aiton A., Lewis G.F., and Adeli K. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J. Biol. Chem. 275 (2000) 8416-8425
20. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957) 497-509
21. Ho S.S., and Pal S. Margarine phytosterols decrease the secretion of atherogenic lipoproteins from HepG2 liver and Caco2 intestinal cells. Atherosclerosis 182 (2005) 29-36
22. Basso F., Freeman L.A., Ko C., Joyce C., Amar M.J., Shamburek R.D., Tansey T., Thomas F., Wu J., Paigen B., Remaley A.T., Santamarina-Fojo S., and Brewer Jr. H.B. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited. J. Lipid Res. 48 (2007) 114-126
23. Greenspan P., and Fowler S.D. Spectrofluorometric studies of the lipid probe, Nile red. J. Lipid Res. 26 (1985) 781-789
24. Cha J.Y., and Repa J.J. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J. Biol. Chem. 282 (2007) 743-751
25. McGarry J.D., Mannaerts G.P., and Foster D.W. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J. Clin. Invest 60 (1977) 265-270
26. Mannaerts G.P., Thomas J., Debeer L.J., McGarry J.D., and Foster D.W. Hepatic fatty acid oxidation and ketogenesis after clofibrate treatment. Biochim. Biophys. Acta 529 (1978) 201-211
27. Corton J.M., Gillespie J.G., Hawley S.A., and Hardie D.G. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?. Eur. J. Biochem. 229 (1995) 558-565
28. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest 114 (2004) 147-152
29. Clarke P.R., and Hardie D.G. Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. EMBO J. 9 (1990) 2439-2446
30. Perdomo G., Commerford S.R., Richard A.M., Adams S.H., Corkey B.E., O'Doherty R.M., and Brown N.F. Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. J. Biol. Chem. 279 (2004) 27177-27186
31. Herrero L., Rubi B., Sebastian D., Serra D., Asins G., Maechler P., Prentki M., and Hegardt F.G. Alteration of the malonyl-CoA/carnitine palmitoyltransferase I interaction in the beta-cell impairs glucose-induced insulin secretion. Diabetes 54 (2005) 462-471
32. Nair S., Diehl A.M., Wiseman M., Farr Jr. G.H., and Perrillo R.P. Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Aliment. Pharmacol. Ther. 20 (2004) 23-28
33. Gibbons G.F., Wiggins D., Brown A.M., and Hebbachi A.M. Synthesis and function of hepatic very-low-density lipoprotein. Biochem. Soc. Trans. 32 (2004) 59-64
34. Fowler S.D., Brown W.J., Warfel J., and Greenspan P. Use of Nile red for the rapid in situ quantitation of lipids on thin-layer chromatograms. J. Lipid Res. 28 (1987) 1225-1232
35. Velasco G., Geelen M.J., and Guzman M. Control of hepatic fatty acid oxidation by 5′-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. Arch. Biochem. Biophys. 337 (1997) 169-175
36. Muoio D.M., Seefeld K., Witters L.A., and Coleman R.A. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J. 338 Pt 3 (1999) 783-791
37. Dixon J.L., Furukawa S., and Ginsberg H.N. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J. Biol. Chem. 266 (1991) 5080-5086
38. Dolinsky V.W., Gilham D., Alam M., Vance D.E., and Lehner R. Triacylglycerol hydrolase: role in intracellular lipid metabolism. Cell Mol. Life Sci. 61 (2004) 1633-1651